A sensitive proliferation assay to determine the specific T cell response against HLA-A2.1-binding peptides

Journal of Immunological Methods

Volumn 197, Issue 1-2, 1996, Pages 131-137

  Mayer, S ^a   Scheibenbogen, C ^a   Lee, K H ^a   Keilholz, W ^b   Stevanovic, S ^b   Rammensee, H G ^b   Keilholz, U ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

cytomegalovirus; ELISPOT; peptide; proliferation; T cell

Indexed keywords

GAMMA INTERFERON; HLA A2 ANTIGEN; SYNTHETIC PEPTIDE; VIRUS ANTIGEN;

ADULT; ARTICLE; CYTOMEGALOVIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS;

EID: 0030590638     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-1759(96)00124-X     Document Type: Article

References (11)

1. Barouch, D., Friede, T., Stevanovic, S., Tussey, L., Smith, K., Rowland-Jones, S., Braud, V., McMicheal, A. and Rammensee, H.-G. (1995) HLA-A2 subtypes are functionally distinct in peptide binding and presentation. J. Exp. Med. 182, 1847-1856.
2. Bednarek, M.A., Sauma, S.Y., Gammon, M.C., Porter, G., Tamhankar, S., Williamson, A.R. and Zweerink, H. (1991) The minimum peptide epitope from the influenza virus matrix protein. J. Immunol. 147, 4047-4053.
3. + T cells. J. Clin. Invest. 94, 797-807.
4. Borysiewicz, L.K., Hickling, J., Grahm, S., Sinclair, J., Cranage, M.P. and Sissons, J.G.P. (1988a) Human CMV-specific cytotoxic T cells. Relative frequency of stage-specifc CTL recognizing the 72 kD Immediate early protein and glycoprotein B expressed by recombinant vaccinia virus. J. Exp. Med. 168, 919-931.
5. Borysiewicz, L.K., Grahm, S., Hickling, J., Mason, P.D. and Sissons, J.G.P. (1988b) Human CMV-specific cytotoxic T cells: their precursor frequency and stage specifity. Eur. J. Immunol. 18, 269-275.
6. Dutz, J.P., Walden, P.R. and Eisen, H.N. (1992) Effects of cognate peptides on cytolytic and proliferative activities of cloned cytotoxic T lymphocytes. Int. Immunol. 4, 571-580.
7. Falk, K., Rötzschke, O., Stevanovic, S., Jung, G. and Rammensee, H.-G. (1991) Allele specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351, 290-296.
8. Parker, K., Bednarek, M., Hull, L.K., Utz, U., Cunningham, B., Zweerink, H.J., Biddison, W.E. and Coligan, J.E. (1992) Sequence motifs important for peptide binding to the human MHC class I molecule HLA-A2. J. Immunol. 149, 2580-2587.
9. Sissons, J.G.P., Borysiewicz, L.K., Rogers, B, and Scott, D. (1986). CMV: its cellular immunology and biology. Immunol. Today 7, 57-62.
10. Utz, U., Koenig, S., Coligan, J.E. and Biddison, W.E. (1992) Presentation of three different viral peptides, HTLV-1 Tax, HCMV gB, and influenza virus M1, is determined by common structural features of the HLA-A2.1 molecule. J. Immunol. 149, 214-221.
11. Walker, B.D., Flexner, C., Birch-Limberger, K., Fisher, L., Paradis, T.J., Aldovini, A., Young, R., Moss, B. and Schooley, R.T. (1989) Long-term culture and fine specifity of human cytotoxic T-lymphocyte clones reactive with HIV type. Proc. Natl. Acad. Sci. 86, 9514-9518.